Intravenous Immunoglobulin (IVIG) in Lung Transplantation
clinical trial
Press Enter · cited answer in seconds
0 sources
Intravenous Immunoglobulin (IVIG) in Lung Transplantation
Summary
Intravenous Immunoglobulin (IVIG) in Lung Transplantation is a clinical trial[1].
Key Facts
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation is in the country of United States[2].
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation's instance of is recorded as clinical trial[3].
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation's start time is recorded as +2005-06-30T00:00:00Z[4].
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation's end time is recorded as +2009-08-31T00:00:00Z[5].
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation's main subject is recorded as agammaglobulinemia[6].
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation's number of participants is recorded as {'unit': '1', 'amount': '+11'}[7].
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation's title is recorded as IVIG for Acquired Immunodeficiency in Lung Transplant Patients[8].
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+12'}[9].
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation's ClinicalTrials.gov ID is recorded as NCT00115778[10].
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}[11].
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation's clinical trial phase is recorded as phase II clinical trial[12].
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation's study type is recorded as interventional study[13].